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The non-ribosomally synthesized lipodepsipeptide CDA belongs to the group of acidic lipopeptide
antibiotics, whose members feature a fatty acid side chain that strongly affects their antimicrobial
activity. This study elucidates the N-acylation of the N-terminal serine in the CDA peptide chain. This
reaction is referred to as lipoinitiation and is shown to be catalyzed by the dissected starter C
domain found at the N-terminus of Cda-PSI. The recombinantly produced C domain speciﬁcally
interacts with 2,3-epoxyhexanoyl-S-ACP and catalyzes the transfer of the fatty acid moiety onto
the amino group of PCP-bound serine with high selectivity for both carrier protein bound substrates
at the donor and acceptor site.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction membrane of Gram-positive bacteria and thus dramatically affectsAcidic lipopeptides constitute an important class of non-riboso-
mally synthesized peptide antibiotics. Daptomycin is probably the
most prominent member of this group, due to its application as a
last-resort antibiotic in cases of infections by multidrug resistant
pathogens, beside other well known representatives like A54145
from Streptomyces fradiae or calcium-dependent antibiotics (CDA)
produced by the model streptomycete Streptomyces coelicolor
A3(2) [1]. Common features of this class are the fatty acid moiety
N-terminally attached to the peptide chain, the conserved position
of D-conﬁgured and achiral amino acids and the Ca2+-binding motif
DxDG [2], which is essential for antibiotic activity by neutralising
the acidic peptide residues thereby improving the binding to bacte-
rial cytosolic membranes [3]. The biosynthesis of the branched cyc-
lic lipodepsipeptide CDA is accomplished by three NRPS enzymes
(Cda-PS1-3) that comprise elevenmodules associatedwith the pep-
tide assembly and cyclization (Fig. 1A) [4]. TheN-terminal lipidmoi-
ety facilitates the penetration of lipopeptides into the plasmachemical Societies. Published by E
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.A. Marahiel).their antimicrobial activity [1,5,6]. Therefore, the nature of the fatty
acid group is important when considering the generation of new
morepotent and less toxic antimicrobial agents. Recently, themech-
anismof activationand tailoringprocesses involved in the formation
of the b-amino fatty acid moiety of the NRP/PK hybrid mycosubtilin
[7] as well as the activation and transfer of the b-hydroxy fatty acid
found in surfactin have been elucidated [8]. The fatty acid moiety in
CDA is a unique 2,3-epoxyhexanoic acid (Fig. 1B) which is invariant
in contrast to all other known lipopeptides of this class where the
fatty acid residues can vary in length or degree of saturation as well
as branching.Within thebiosynthetic gene cluster of CDA, a putative
fatty acid biosynthesis (fab) cluster encoding ﬁve proteins proposed
to be involved in the synthesis and modiﬁcation of 2,3-epoxyhexa-
noic acid (Fig. 1C)was identiﬁed. The gene SCO3249 encodes an acyl
carrier protein (ACP) similar to ACPs from fatty acid and polyketide
synthases. The gene products FabF3 and FabH4 share the highest
homology to b-ketoacyl-ACP synthase KAS-II and -III enzymes,
respectively. These are proposed to be involved in the synthesis of
hexanoyl-S-ACP (Fig. 1C). In contrast, HxcO and HcmO have been
shown to be a FAD-dependent hexanoyl-ACP oxidase and a hexe-
noyl-ACP monooxygenase, respectively, and were shown in vitro
to generate the epoxy group found in the fatty acid side chain of
CDA [9].
In this study we focus on the transfer reaction of the fatty acid
moiety (FA) onto the peptide chain of CDA which is shown to be
catalyzed by the excised initiation C domain of the ﬁrst NRPSlsevier B.V. All rights reserved.
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Fig. 1. Biosynthesis and structure of CDA. (A) Domain organization of the three CDA synthetases CdaPS1–3. C domains are shown in grey, A domains in red, PCP domains in
green, E domains in blue and the TE domain in orange. Hpg: hydroxyphenyl-glycine; MeGlu: methyl-glutamate; (B) Structure of CDA4b produced by Streptomyces coelicolor
A3(2), the fatty acid moiety is highlighted in blue; (C) The fab genes of the CDA biosynthetic gene cluster and the putative mechanism of fatty acid biosynthesis prior to
incorporation into the peptide chain.
284 F.I. Kraas et al. / FEBS Letters 586 (2012) 283–288subunit Cda-PS1. The results obtained in this study enable new in-
sights into the lipoinitiation reaction mechanism by identifying the
carrier protein(CP)-bound substrates involved and deﬁning the
substrate speciﬁcity of the starter C domain.
2. Materials and methods
Materials and methods are described in the Supplementary
data.
3. Results
3.1. Puriﬁcation of proteins and assembly of FA-S-ACP and AA-S-PCP
Since this study aimed to investigate the initiation of CDA
biosynthesis, which is the acylation of the N-terminal serine
with 2,3-epoxyhexanoic acid, all proteins involved in this reac-
tion were heterologously produced. The epoxidation enzymes
HxcO and HcmO as well as the acyl carrier protein SCO3249
were expressed and puriﬁed as previously described [9]. Since
heterologous expression of the entire initiation module of the
CDA synthetase CdaPS1 produced unsoluble protein despite dif-
ferent attempts to increase solubility by altering domain borders
and testing various expression conditions, we decided to excise
and express the C domain (Cda-C1) as a singular protein. This
approach was recently shown to generate a soluble and active
initiation C domain in the surfactin system [8]. Cda-C1 was
cloned into a pET28a(+) derived vector and expressed in Esche-
richia coli BL21(DE3). The subsequent puriﬁcation by Ni2+-NTA
afﬁnity chromatography yielded 2.6 mg/L culture of the C do-
main as a C-terminally His6-tagged protein. The variants
H156A and H157A of the C domain containing point mutationsof the putative catalytic motif HHxxxDG were constructed by
site-directed mutagenesis. The variant H157A could be obtained
in a comparable yield to the parental protein of about 2.5 mg/L
culture. In contrast, the variant H156A generated unsoluble pro-
tein under various expression conditions. Since the dedicated
peptidyl carrier protein (PCP) domain from the initiation module
of CdaPS1 could not be expressed as a recombinant protein, we
used the homologous PCP domains of the surfactin synthetase
SrfAA and of the daptomycin synthetase DptA. All proteins were
identiﬁed by SDS–PAGE and subsequent mass spectrometry after
tryptic digestion (Fig. S1).
To obtain the putative C domain substrates 2,3-epoxyhexanoyl-
S-ACP and Ser-S-PCP, the corresponding chemically synthesized
CoA thioesters were used with the promiscous 40-phosphopantet-
heinyl transferase Sfp to convert the apo-carrier proteins to their
active holo-forms (Fig. 2). Epoxidation of hexanoyl-ACP was
accomplished by incubation with HxcO or HcmO and the cofactors
FAD and NADH. To remove Sfp and the epoxidation enzyme, the
modiﬁed carrier proteins were subjected to size exclusion chroma-
tography (Fig. S2). To verify the proper loading state of CPs, sam-
ples were subjected to mass spectrometric analysis. In all cases,
the correct loading state could be conﬁrmed. Additionally, signals
of holo-CPs were observed, resulting from substrate release
through thioester hydrolysis (Fig. S3).
3.2. Condensation reaction catalyzed by Cda-C1
To investigate the catalytic activity of the dissected C domain
Cda-C1, assays containing the puriﬁed C domain Cda-C1 and the
substrates 2,3-epoxyhexanoyl-S-ACP (FA-ACP) and Ser-S-PCP were
performed (Fig. 2). Control reactions were conducted by omitting
the C domain from the reaction mixture. After incubation, the
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Fig. 2. Strategy for the investigation of the lipoinitiation in CDA biosynthesis. Apo-CPs are ﬁrst loaded with the corresponding CoA thioesters by Sfp (1,2). Gel ﬁltrated loaded
CPs are then incubated with the excised C domain Cda-C1 (3) and analyzed by mass spectrometry (4). Putative catalytic sites within the C domain: d: donor site; a: acceptor
site.
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reconstruction was accomplished using ProMass Deconvolution
for Xcalibur version 2.1. In the control reaction, masses of FA-
ACP, Ser-PCP and of the respective holo-CPs could be identiﬁed
(Fig. 3A, blue trace). In the reaction mixture containing the excised
C domain, new signals at retention times of 16.5 and 26.8 min were
detected, corresponding to the masses of the C domain and the ex-
pected condensation product 2,3-epoxyhexanoyl-serinoyl-S-PCP,
respectively (Fig. 3A, red trace and Fig. 3B). Additionally, the peak
area at 12.7 min is signiﬁcantly increased, due to the accumulation
of holo-ACP, which is also a product of the transfer reaction. The
signal for the FA-ACP at 15.2 min decreases after incubation with
the C domain in accordance with the fact that the fatty acid moiety
is transferred onto the PCP-bound serine.
Previous biochemical and structural studies on C domains re-
vealed the highly conserved HHxxxDG motif located in the active
site of the protein that is associated with peptide bond formation
[10–14]. Mutational studies of the second histidine of this motif
in several C domains led to the loss of amide bond formation activ-
ity [8,12,15]. Therefore, we generated the Cda-C1 H156A and
H157A variants by site-directed mutagenesis to test them in the
condensation reaction. The Cda-C1 H157A variant resulted in a sol-
uble protein that was unable to catalyze the condensation reaction
to generate 2,3-epoxyhexanoyl-serinoyl-S-PCP (Fig. S4). Unfortu-
nately, the variant H156A generated unsoluble protein and there-
fore was not tested.
To further characterize the C domain, substrate speciﬁcity at its
donor and acceptor site was investigated using several substrates
(Table 1). At the donor site of the C domain, only ACP-bound 2,3-
epoxyhexanoic acid and to a certain extent also 2,3-epoxyoctanoic
acid were accepted as electrophiles for the acylation of Ser-S-PCP.
The stereoconformation of the epoxy group had no strong effect on
the transfer reaction. We observed slightly more product formation
when (2R,3S)-epoxyhexanoyl-ACP was used which is the product
of epoxidation with HxcO, while HcmO gives the (2S,3R)-conﬁg-
ured product. None of the other tested fatty acids, which differedin length from four to ten carbon atoms and the presence or ab-
sence of epoxidation, were valid substrates (Table 1). To elucidate
the speciﬁcity of ACP/C domain interaction at the donor site, the
ACP was substituted by DptF, an ACP from daptomycin biosynthe-
sis [16], and AcpK, which is involved in polyketide biosynthesis in
Bacillus subtilis [17]. In both cases, loading with hexanoic acid and
epoxidation by HxcO and HcmO could be achieved (Table S1), but
transfer of 2,3-epoxyhexanoic acid onto serine was not observed.
The acceptor site showed a considerably more relaxed speciﬁc-
ity with regard to the carrier protein used. Both tested PCP do-
mains, the initial PCP domains from SrfAA and DptA, could be
loaded with serine and were acylated with the fatty acid moiety
in the presence of Cda-C1. However, the amino acid tethered to
the PCP domain could not be arbitrarily substituted. Beside serine,
only threonine was accepted for acylation to a certain extent. Acyl-
ation of the other tested amino acids (lysine, asparagine or gluta-
mate) could not be observed (Table 1).4. Discussion
Lipopeptides feature a fatty acid moiety linked to the N-termi-
nus of the peptide chain and all NRPS catalyzing this reaction con-
tain an N-terminal C domain that is putatively assigned for the
selection and incorporation of the fatty acid into the peptide chain.
This step being the ﬁrst in natural product assembly is thus re-
ferred to as lipoinitiation.
In this studywe explore the speciﬁcity and themechanism of the
lipoinitiation reaction of the peptide assembly line in CDA biosyn-
thesis, by using the dissected starter C domain Cda-C1 to character-
ize the N-acylation of the N-terminal amino acid serine. The
biosynthesis of the fatty acid moiety, 2,3-epoxyhexanoic acid, oc-
curs directly on the ACP SCO3249 through gene products of the fab
genes located in the CDA biosynthetic gene cluster and probably
by enzymes from the primary metabolism [4,9]. This study proves
that 2,3-epoxyhexanoyl-ACP is directly used as a substrate by
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thiolation. The utilization of the fatty acid as a carrier protein bound
intermediate in the N-acylation reaction of CDA describes a novel
mechanism for the lipoinitiation in NRP biosynthesis. In the surfac-
tin system, it has been shown that the fatty acid moiety is activated
in trans as a CoA thioester by fatty acyl CoA ligases from the primary
metabolism and then directly incorporated into the peptide [8]. In
the case of CDA, several genes in the biosynthetic cluster are needed
for fatty acid biosynthesis and activation whose homologues are
missing in the biosynthetic gene cluster of surfactin.
The interaction between the ACP encoded in the CDA gene clus-
ter and the starter C domain seems to be highly speciﬁc as this CP
could not be replaced by other ACPs such as DptF or AcpK [16,17].
It has been shown in several cases that residues belonging to helix-
II, loop2 and helixIII of different CPs are involved in speciﬁc pro-
tein-protein interactions [18,19]. For NRPSs it was shown that
the communication between different synthetases occurs via
speciﬁc residues located in the linker regions deﬁned as the com-
motifs [20]. If similar interaction mechanisms can be found be-
tween Cda-C1 and ACP remains to be clariﬁed. The generally highspeciﬁcity of the C domain for the incoming CP-bound substrates
both at the acceptor and the donor site assures a correct assembly
of the natural product [1,5,6]. Especially for proteins acting in trans,
as it is the case during lipoinitiation of CDA biosynthesis, a speciﬁc
interaction is important to allow the incorporation of the correct
building blocks. This may explain the high speciﬁcity of the starter
C domain at its donor site for the acyl-ACP. In contrast, Cda-C1
shows a relaxed speciﬁcity for the CP at the acceptor site but high
selectivity for the attached substrate. This makes the C domain a
challenging target for domain swapping to generate new
lipopeptides.
In vivo studies in Streptomyces coelicolor showed that alteration
or deletion of enzymes synthesizing the fatty acid moiety leads to
new variants of CDA that points towards a somehow relaxed speci-
ﬁcity during this lipoinitiation reaction [21,22]. The deletion of hxcO
leads to the production of a hexanoyl-CDA variant, which lacks the
epoxide group found in wild-type CDA [22]. In contrast, the transfer
of the hexanoyl residuewas not observed in our in vitro studies. The
accumulation of hexanoyl-S-ACP in the deletionmutant strain could
shift the equilibrium towards the products andwould therefore lead
Table 1
Substrate speciﬁcity of the C domain Cda-C1 for the N-acylation of aminoacyl-PCP.
Substrate at donor site Mexp. (acyl-Ser-PCP)a/Da Mcalc. (acyl-Ser-PCP)a/Da
Fatty acids Butanoic acid – 12758.4
Epoxybutanoic acid – 12772.4
Hexanoic acid – 12871.4
2,3-Epoxyhexanoic acid 12887.1 12887.6
Octanoic acid – 12899.4
2,3-Epoxyoctanoic acid 12914.6 12915.6
Decanoic acid – 12927.4
ACPs DptF – 12887.6
AcpK – 12887.6
Substrate at acceptor site Mexp. (epoxyhexanoyl-aa-PCP)a/Da Mcalc. (epoxyhexanoyl-aa-PCP)a/Da
Amino acids Ser 12887.1 12887.6
Thr 12900.4 12901.6
Lys – 12928.2
Asn – 12914.6
Glu – 12929.6
PCPs SrfAA-PCP1 11339.0 11338.2
DptA-PCP1 12887.1 12887.6
Reaction products which were not detected are indicated with dashes ().
a In studies where the donor site and the amino acid at the acceptor site were varied DptA-PCP1 was used as the CP at the acceptor site.
F.I. Kraas et al. / FEBS Letters 586 (2012) 283–288 287to the saturated fatty acid in the CDA derivative. The same could be
true for the observed incorporation of butanoic and 2,3-epoxybuta-
noic acid in vivo through modiﬁcation of the FabF3 speciﬁcity [21],
which was not observed in our in vitro study using the excised star-
ter C domain.
The lipoinitiation in CDA biosynthesis describes a new third dis-
tinct mechanism for this reaction beside those observed in the
NRP/PK hybrid mycosubtilin and the pure NRP surfactin systems
[7,8]. The mechanisms of lipoinitiation in surfactin and CDA bio-
synthesis are quite similar, however differring in the mode of fatty
acid activation. The starter C domain of the surfactin synthetase se-
lects a CoA-activated fatty acid, whereas the C domain Cda-C1 uses
2,3-epoxyhexanoic acid tethered to an ACP, which is probably rec-
ognized by additional protein–protein interaction. The biosyn-
thetic gene cluster of daptomycin, a related lipopeptide antibiotic
that is in clinical use since 2003 [23], also contains a dedicated
ACP and a starter C domain with high homology to Cda-C1 (39%
identity, 52% similarity) pointing towards a more widespread utili-
zation of this lipoinitiation mechanism [24].
All known classes of C domains associated with amide bond for-
mation share a common catalytic core motif HHxxxDG, including
starter C domains like Cda-C1 [11]. The substitution of the second
histidine (H157) in Cda-C1 by alanine led to an inactive protein. This
is in agreement with previous biochemical and structural studies of
C domains in which the second histidine of this core motif was
shown to be essential for the catalytic activity. This points towards
a common mechanism of amide bond formation in C domain cata-
lyzed reactions during elongation and initiation [8,12,15].
In conclusion, this study provides detailed insight into a new
mechanism of lipoinitiation in acidic lipopeptide biosynthesis that
broaden our understanding of lipopeptide biosynthesis by deﬁning
substrates involved and selectivities in the lipoinitiation reaction
of CDA biosynthesis. This knowledge is necessary for the further
development of drug design strategies employing techniques like
domain swapping or alteration of enzymes involved in the synthe-
sis of the fatty acid moieties found in lipopeptides.
Acknowledgments
We thankDr. Uwe Linne and themass spectrometric department
for carrying outMSmeasurements, KathrinHnida and Linda Boss for
their support of this study. We gratefully acknowledge ﬁnancialsupport fromtheDeutsche Forschungsgemeinschaft and the LOEWE
Center for Synthetic Microbiology in Marburg (SYNMIKRO).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2012.01.003.
References
[1] Baltz, R.H., Miao, V. and Wrigley, S.K. (2005) Natural products to drugs:
daptomycin and related lipopeptide antibiotics. Nat. Prod. Rep. 22, 717–741.
[2] Strieker, M. and Marahiel, M.A. (2009) The structural diversity of acidic
lipopeptide antibiotics. ChemBioChem 10, 607–616.
[3] Straus, S.K. and Hancock, R.E. (2006) Mode of action of the new antibiotic for
Gram-positive pathogens daptomycin: comparison with cationic
antimicrobial peptides and lipopeptides. Biochim. Biophys. Acta 1758, 1215–
1223.
[4] Hojati, Z. et al. (2002) Structure, biosynthetic origin, and engineered
biosynthesis of calcium-dependent antibiotics from Streptomyces coelicolor.
Chem. Biol. 9, 1175–1187.
[5] Counter, F.T. et al. (1990) A54145 a new lipopeptide antibiotic complex:
microbiological evaluation. J. Antibiot. (Tokyo) 43, 616–622.
[6] Debono, M. et al. (1988) Enzymatic and chemical modiﬁcations of lipopeptide
antibiotic A21978C: the synthesis and evaluation of daptomycin (LY146032). J.
Antibiot. (Tokyo) 41, 1093–1105.
[7] Hansen, D.B., Bumpus, S.B., Aron, Z.D., Kelleher, N.L. and Walsh, C.T. (2007) The
loading module of mycosubtilin: an adenylation domain with fatty acid
selectivity. J. Am. Chem. Soc. 129, 6366–6367.
[8] Kraas, F.I., Helmetag, V., Wittmann, M., Strieker, M. and Marahiel, M.A. (2010)
Functional dissection of surfactin synthetase initiation module reveals insights
into the mechanism of lipoinitiation. Chem. Biol. 17, 872–880.
[9] Kopp, F., Linne, U., Oberthur, M. and Marahiel, M.A. (2008) Harnessing the
chemical activation inherent to carrier protein-bound thioesters for the
characterization of lipopeptide fatty acid tailoring enzymes. J. Am. Chem.
Soc. 130, 2656–2666.
[10] De Crecy-Lagard, V., Marliere, P. and Saurin, W. (1995) Multienzymatic non
ribosomal peptide biosynthesis: identiﬁcation of the functional domains
catalysing peptide elongation and epimerisation. C. R. Acad. Sci. III 318, 927–
936.
[11] Rausch, C., Hoof, I., Weber, T., Wohlleben, W. and Huson, D.H. (2007)
Phylogenetic analysis of condensation domains in NRPS sheds light on their
functional evolution. BMC Evol. Biol. 7, 78.
[12] Stachelhaus, T., Mootz, H.D., Bergendahl, V. and Marahiel, M.A. (1998) Peptide
bond formation in nonribosomal peptide biosynthesis. Catalytic role of the
condensation domain. J. Biol. Chem. 273, 22773–22781.
[13] Vater, J., Stein, T., Vollenbroich, D., Kruft, V., Wittmann-Liebold, B., Franke, P.,
Liu, L. and Zuber, P. (1997) The modular organization of multifunctional
peptide synthetases. J. Protein Chem. 16, 557–564.
[14] Samel, S.A., Schoenaﬁnger, G., Knappe, T.A., Marahiel, M.A. and Essen, L.O.
(2007) Structural and functional insights into a peptide bond-forming
bidomain from a nonribosomal peptide synthetase. Structure 15, 781–792.
288 F.I. Kraas et al. / FEBS Letters 586 (2012) 283–288[15] Roche, E.D. andWalsh, C.T. (2003) Dissection of the EntF condensation domain
boundary and active site residues in nonribosomal peptide synthesis.
Biochemistry 42, 1334–1344.
[16] Miao, V. et al. (2005) Daptomycin biosynthesis in Streptomyces roseosporus:
cloning and analysis of the gene cluster and revision of peptide
stereochemistry. Microbiology 151, 1507–1523.
[17] Calderone, C.T., Kowtoniuk, W.E., Kelleher, N.L., Walsh, C.T. and Dorrestein,
P.C. (2006) Convergence of isoprene and polyketide biosynthetic machinery:
isoprenyl-S-carrier proteins in the pksX pathway of Bacillus subtilis. Proc.
Natl. Acad. Sci. USA 103, 8977–8982.
[18] Alekseyev, V.Y., Liu, C.W., Cane, D.E., Puglisi, J.D. and Khosla, C. (2007) Solution
structure and proposed domain domain recognition interface of an acyl carrier
protein domain from a modular polyketide synthase. Protein Sci. 16, 2093–
2107.
[19] Lai, J.R., Fischbach, M.A., Liu, D.R. and Walsh, C.T. (2006) A protein interaction
surface in nonribosomal peptide synthesis mapped by combinatorial
mutagenesis and selection. Proc. Natl. Acad. Sci. USA 103, 5314–5319.[20] Hahn, M. and Stachelhaus, T. (2004) Selective interaction between
nonribosomal peptide synthetases is facilitated by short communication-
mediating domains. Proc. Natl. Acad. Sci. USA 101, 15585–15590.
[21] Lewis, R.A., Nunns, L., Thirlway, J., Carroll, K., Smith, C.P. and Mickleﬁeld, J.
(2011) Active site modiﬁcation of the beta-ketoacyl-ACP synthase FabF3 of
Streptomyces coelicolor affects the fatty acid chain length of the CDA
lipopeptides. Chem. Commun. (Camb.) 47, 1860–1862.
[22] Powell, A., Borg, M., Amir-Heidari, B., Neary, J.M., Thirlway, J., Wilkinson, B.,
Smith, C.P. and Mickleﬁeld, J. (2007) Engineered biosynthesis of nonribosomal
lipopeptides with modiﬁed fatty acid side chains. J. Am. Chem. Soc. 129,
15182–15191.
[23] Kirkpatrick, P., Raja, A., LaBonte, J. and Lebbos, J. (2003) Daptomycin. Nat. Rev.
Drug Disc. 2, 943–944.
[24] Wittmann, M., Linne, U., Pohlmann, V. and Marahiel, M.A. (2008) Role of DptE
and DptF in the lipidation reaction of daptomycin. FEBS J. 275, 5343–5354.
